izpis_h1_title_alt

Combinatory effect of nitroxoline and gentamicin in the control of uropathogenic enterococci infections
ID Repac Antić, Davorka (Author), ID Kovač, Bruno (Author), ID Kolenc, Marko (Author), ID Brčić Karačonji, Irena (Author), ID Gobin, Ivana (Author), ID Petković Didović, Mirna (Author)

.pdfPDF - Presentation file, Download (2,07 MB)
MD5: AEA6565F8B1A90B138B44C90761A05D0
URLURL - Source URL, Visit https://www.mdpi.com/2079-6382/13/9/829 This link opens in a new window

Abstract
Enterococcus faecalis, responsible for a majority of human and nosocomial enterococcal infections, is intrinsically resistant to aminoglycoside antibiotics (such as gentamicin, GEN), which must be used in a combined therapy to be effective. Nitroxoline (NTX) is an old antibiotic, underused for decades, but rediscovered now in an era of growing antibiotic resistance. In this in vitro study, the types of interactions between NTX and GEN on 29 E. faecalis strains were analyzed with an aim to find synergistic antimicrobial and antiadhesion combinations. Transmission electron microscopy (TEM) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) were used to analyze changes in cell morphology and bacterial proteome after monotreatments and combined treatments. The results showed the synergistic effect for six combinations on eight strains, including the ATCC29212, and an additive effect for most strains. Combinations causing a complete inhibition of adhesion were established. Cell membrane integrity was affected by NTX, while combined NTX/GEN treatment caused dramatic changes in cell morphology. Upregulation of the expression of many proteins was established, with some emerging only after combined treatment. The results strongly imply that NTX has the potential for use in combined therapy with GEN against enterococci and it could further provide a substantial contribution to an ongoing fight against antimicrobial resistance and nosocomial infections.

Language:English
Keywords:synergism, enterococci, E. faecalis, antiadhesion, proteome, antimicrobial resistance
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FGG - Faculty of Civil and Geodetic Engineering
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:19 str.
Numbering:Vol. 13, iss. 9, art. 829
PID:20.500.12556/RUL-161268-ea564a48-f2f1-6ade-3ffd-9c7a92770f9e This link opens in a new window
UDC:615
ISSN on article:2079-6382
DOI:10.3390/antibiotics13090829 This link opens in a new window
COBISS.SI-ID:206514691 This link opens in a new window
Publication date in RUL:09.09.2024
Views:59
Downloads:35
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Antibiotics
Shortened title:Antibiotics
Publisher:MDPI AG
ISSN:2079-6382
COBISS.SI-ID:522975769 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:sinergizem, enterokoki, E. faecalis, antiadhezija, proteom, protimikrobna odpornost

Projects

Funder:Other - Other funder or multiple funders
Funding programme:University of Rijeka grants
Project number:uniri-iskusni-prirod-23-92

Funder:Other - Other funder or multiple funders
Funding programme:University of Rijeka grants
Project number:uniri-iskusni-biomed-23-110

Funder:Other - Other funder or multiple funders
Funding programme:European Regional Development Fund
Project number:KK.01.1.1.02.0007 (Rec-IMI)

Funder:Other - Other funder or multiple funders
Funding programme:European Union—Next Generation
Project number:EU 533-03-23-0006 (BioMolTox)

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back